ALXN
Alexion Pharmaceuticals Inc
Price:  
182.50 
USD
Volume:  
15,135,410.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alexion Relative Valuation

-49.1%
Upside

As of 2024-05-20, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 92.89 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -49.1%.

The range of the Relative Valuation is 75.75 - 131.70 USD.

Range Selected
Trailing P/E multiples 31.6x - 42.8x 35.2x
Forward P/E multiples 29.2x - 33.7x 29.8x
Fair Price 75.75 - 131.70 92.89
Upside -58.5% - -27.8% -49.1%
182.50 USD
Stock Price
92.89 USD
Fair Price

Alexion Relative Valuation - Historical P/E Data

Date P/E